EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

An Updated Review on Memantine Efficacy in Reducing Cognitive Dysfunction of Whole-brain Irradiation for Adult Patients with Brain metastasis

Anya Jafari, Zahra Siavashpour, Mohammad Houshyari

International Journal of Cancer Management · 19.04.2021 · 14 (4)

DOI: 10.5812/ijcm.111966 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Cancer Management, online erschienen am 19.04.2021. Verfasst von Anya Jafari und 2 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Increased survival of patients with cancer raises the need to pay attention to long-term side effects. Patients with brain metastasis experienced cognition failure after whole-brain radiotherapy. This review aimed at concluding the efficacy of Memantine in preserving cognitive function by reducing the brain toxicity of whole-brain radiotherapy for metastatic brain cancers. Evidence Acquisition: Published studies evaluating memantine protective effects during brain metastasis radiotherapy were searched for in scientific databases (e.g., Embase, PubMed, Cochrane database, Google Scholar, Scopus) using keywords including whole-brain radiotherapy and Memantine.

Results

A total of 4 prospective clinical trials were included in the review. Effects of Memantine on cognition tests were evaluated in these trials. A significantly better Hopkins Verbal Learning Test-Revised (HVLT-R) delayed recognition at months 6 was achieved in RTOG 0614 and NRG CC001. Longer time to cognitive decline was found in the memantine arm of the RTOG trial and was statistically significant. Memantine effects were not statistically significant before 2 months.

Conclusions

It seems reasonable to consider Memantine during radiation to prevent long-term cognitive failure in patients with brain metastasis due to the current results. Memantine improves cognition function during whole-brain radiotherapy (WBRT) without adding irreparable complications.

Zitieren

APA

Jafari, A., Siavashpour, Z., & Houshyari, M. (2021). An Updated Review on Memantine Efficacy in Reducing Cognitive Dysfunction of Whole-brain Irradiation for Adult Patients with Brain metastasis. International Journal of Cancer Management, 14(4). https://doi.org/10.5812/ijcm.111966

Vancouver

Jafari A, Siavashpour Z, Houshyari M. An Updated Review on Memantine Efficacy in Reducing Cognitive Dysfunction of Whole-brain Irradiation for Adult Patients with Brain metastasis. International Journal of Cancer Management. 2021;14(4). doi:10.5812/ijcm.111966

BibTeX
@article{Jafari2021,
  author = {Jafari, Anya and Siavashpour, Zahra and Houshyari, Mohammad},
  title = {An Updated Review on Memantine Efficacy in Reducing Cognitive Dysfunction of Whole-brain Irradiation for Adult Patients with Brain metastasis},
  journal = {International Journal of Cancer Management},
  year = {2021},
  volume = {14},
  number = {4},
  doi = {10.5812/ijcm.111966}
}
Kostenlos starten →